Skip to content

Insider · CIK 0001474553

William Ashton

director

Files at SCTL (Societal CDMO, Inc.), MDCX (Medicus Pharma Ltd.). First filing -, latest -.

In brief

William Ashton files SEC Form 4 as director at SCTL (Societal CDMO, Inc.), and also at MDCX (Medicus Pharma Ltd.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; William Ashton has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 8 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 3, 2026MDCX
Medicus Pharma Ltd.
AGrant or award
Stock Option (right to buy)derivative
+50,000$0.00$050,000Jun 4, 2026
Mar 30, 2026MDCX
Medicus Pharma Ltd.
AGrant or award
Stock Option (right to buy)derivative
+25,000$0.00$025,000Apr 1, 2026
Dec 16, 2025MDCX
Medicus Pharma Ltd.
AGrant or award
Stock Option (right to buy)derivative
+25,000$0.00$025,000Dec 18, 2025
Jul 22, 2025MDCX
Medicus Pharma Ltd.
AGrant or award
Stock Option (right to buy)derivative
+25,000$0.00$025,000Jul 24, 2025
Apr 8, 2024SCTL
Societal CDMO, Inc.
UTender of shares
Common Stock
-190,002$1.10$209k73,620Apr 8, 2024
Apr 8, 2024SCTL
Societal CDMO, Inc.
DDisposition to issuer
Common Stock
-73,620$1.10$81k0Apr 8, 2024
Apr 8, 2024SCTL
Societal CDMO, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-118,182--0Apr 8, 2024
Apr 8, 2024SCTL
Societal CDMO, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-27,229--0Apr 8, 2024

Questions about William Ashton

Answered from the filings on this page, as of the latest one.

Is William Ashton buying or selling?

William Ashton has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did William Ashton's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and William Ashton has 0.

Where does William Ashton file Form 4?

William Ashton has filed Form 4 at SCTL (Societal CDMO, Inc.); MDCX (Medicus Pharma Ltd.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

William Ashton: insider trades and track record | InsiderTell